You are here: Industry Insights > Clinical Trials

News List

Innovent's PD-1 suffered setbacks in the listing of overseas market, a paradigm for Chinese innovative drug in the global market PharmaSources/Caicai
February 22, 2022
Recently, FDA held an ODAC (Oncologic Drugs Advisory Committee) meeting around the key event in the listing application of Sintilimab, Innovent's PD-1 monoclonal antibody, in the United States.
Decentralized Clinical Trials— The Tomorrow of Clinical Research Lin Zhang
April 07, 2021
The Coronavirus disease 2019 (COVID-19) pandemic has led to many changes in the way different processes are handled. In particular, it is profoundly disrupting clinical research.
Getting Clinical Trials Back on Track Sarah Harding
February 04, 2021
I think it is fair to say that R&D is the lifeblood of the pharma industry, and no drug discovery program can be completed without its clinical trials.
CDE Issues Document to Promote the Launch Progress of COVID-19 Vaccines, Global Overiew of 7 Vaccine Clinical Trials PharmaSources/Xiaoyaowan
August 21, 2020
CDE Issues Document to Promote the Launch Progress of COVID-19 Vaccines, Global Overiew of 7 Clinical Trials.
The Impact of Coronavirus (COVID-19) on Global Pharmaceutical Industry Lin Zhang
April 13, 2020
Alongside the human impact of COVID-19 pandemic outbreak and the economic downfall caused by its spread, COVID-19 is having a growing impact on the global pharmaceutical industry.
China Disclosed Research Data of PiCoVacc, an Inactivated Virus Vaccine against COVID-19 CPhI.CN
April 21, 2020
On April 19, the Chinese Academy of Medical Sciences uploaded an article entitled "Rapid development of an inactivated vaccine for SARS-CoV-2" in BioRxiv.
First-in-Human Clinical Data Shows SonoTran® is Safe and Well-Tolerated PharmaSources
January 23, 2023
OxSonics Therapeutics, announces that first-in-human clinical data demonstrated that SonoTran® is safe and well-tolerated, with consistent Particle activation observed and mapped using OxSonics’ proprietary “see-as-you-treat” technology.
Biogen urges Medicare to reverse proposed limits on coverage of Alzheimer's drug FirstWordPharma
February 11, 2022
Biogen is urging Medicare to broadly reimburse its Alzheimer's drug Aduhelnm, in response to a proposal by the US Centers for Medicaid and Medicare Services (CMS) to sharply limit coverage of new drugs for the disease...
Tools4Patient Announces Name Change to Cognivia & Expands Board of Directors prnasia
January 06, 2022
Cognivia today announced a new name for the company formerly known as Tools4Patient, which provides clinical trials solutions based on AI / ML that account for individual patient personality traits...
ITC starts clinical trials of nasal spray for COVID-19 prevention ExpressPharma
November 26, 2021
ITC yesterday confirmed that it is developing a nasal spray for COVID-19 prevention for which it has initiated clinical trials.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 13 14 Next page